Location: Israel, Jerusalem District, Jerusalem
Employees: 11-50
Total raised: $14.2M
Founded date: 2011
Funding Rounds 3
| Date | Series | Amount | Investors |
| 09.01.2025 | - | $6.6M | - |
| 09.03.2021 | - | $2.6M | - |
| 24.10.2019 | Series A | $5M | - |
Mentions in press and media 8
| Date | Title | Description |
| 11.01.2025 | Pepticom's $6.6 Million Leap: A New Era in Autoimmune Treatment | Pepticom is on the cutting edge of medical innovation. The company recently secured $6.6 million in a Series A1 funding round, led by Japan Israel High Tech Ventures 2 LP. This funding is not just a financial boost; it’s a catalyst for chan... |
| 09.01.2025 | Pepticom: Peptide-Based Therapeutics Company Raises $6.6 Million (Series A1) | Pepticom, a pioneer in AI-based peptide-based therapeutics, announced the completion of its Series A1 funding round, securing $6.6 million. Japan Israel High Tech Ventures 2 LP led the round, with strong participation from existing investor... |
| 07.01.2025 | Pepticom Secures $6.6M to Advance AI-Powered Peptide Drug Discovery | What You Should Know: – Pepticom, an innovator in AI-driven peptide-based therapeutics secures $6.6M in a Series A1 funding round led by Japan Israel High Tech Ventures 2 LP, with strong support from existing investors. – The new funding wi... |
| 09.03.2021 | Jerusalem-based AI drug design firm Pepticom raises $2.6 million to focus on COVID-19 treatments via PeptiCov | Realising that we’re all going to be living side by side with the SARS-Cov-2 virus for the next foreseeable future, Israeli AI powered drug design and discovery company Pepticom has raised $2.6 million to spin out PeptiCov. The investment i... |
| 09.03.2021 | Pepticom's New Spinout Company, PeptiCov, to Focus on COVID-19 | JERUSALEM, March 9, 2021 /PRNewswire/ -- Pepticom, a leader in artificial intelligence peptide drug design and discovery, announced today that it has raised $2.6 million to establish a company to focus on treatments for the SARS-Cov-2 virus... |
| 24.10.2019 | Pepticom Secures $5M in Series A Funding | Pepticom, a Jerusalem, Israel-based startup that uses AI to accelerate drug discovery, raised $5m in Series A funding. The Chartered Group made the strategic investment. The company intends to use the funds for the development of new AI mod... |
| 24.10.2019 | Israeli AI tech startup Pepticom raises $5M Series A to accelerate drug discovery | Peptides are used in various therapies, and are recognized for being highly selective and efficacious as well as relatively safe. The pharma industry has recently shown an increased interest in peptide research and development, leading to a... |
| - | Pepticom Ltd. | “Pepticom – Pepticom” |